Can Mounjaro Cause Headaches — and What Can You Do About Them?

The biggest myth: headaches mean something has gone wrong

The most common assumption people bring to this question is that a headache on Mounjaro signals a problem with the medicine itself, an intolerance, a reaction, a reason to stop. That is rarely the picture. Headaches on tirzepatide are nearly always a secondary effect rather than a direct pharmacological one. The medicine works partly by slowing gastric emptying and suppressing appetite, which can reduce how much you eat and drink in those first weeks. Less food and, crucially, less fluid is the real culprit for most people. Mild dehydration is one of the most reliable headache triggers in general, and it is easy to let fluid intake slip when you are not feeling particularly hungry or thirsty.

The NHS medicines page for tirzepatide lists headache among the known side effects, alongside the gastrointestinal symptoms that tend to get more attention. Seeing it on that list does not mean you are certain to experience it, it means enough people reported it during clinical development for it to be documented. Knowing that makes it less alarming and easier to manage. Our overview of Mounjaro side effects covers the broader picture if you want fuller context.

If you are asking does Mounjaro cause headaches because you are currently experiencing them, read on, the next section is for you.

When headaches on Mounjaro are most likely, and why they usually pass

Headaches on tirzepatide tend to cluster around two moments: the very start of treatment, and the days after a dose increase. Both are points at which the body is adjusting to a new pharmacological signal, and both are points at which eating and drinking patterns often shift most sharply. That timing is a useful clue. If your headache arrived within a day or two of starting a new pen or a higher dose, a dose-adjustment effect is the most plausible explanation.

Practically, the things that help most people are straightforward: drink more water than you think you need, especially in the morning; eat regularly even if portions are small; and avoid skipping meals entirely in the early weeks, which can compound low-grade hypoglycaemia-adjacent symptoms even in people without diabetes. Rest matters too. None of that is complicated, but it is easy to overlook when the focus is on the medicine itself.

Headaches that track with nausea and settle within a week or two are typical of the adjustment period. The detailed guide to headaches on Mounjaro goes into the day-by-day pattern in more depth, including what participants in the SURMOUNT trials reported about timing. The short version: for most people, this is a self-limiting phase rather than a persistent problem.

If you want to understand the mechanism more fully, the page on why Mounjaro causes headaches covers the dehydration, gastric-emptying and appetite-suppression pathways in plain language.

When to get medical help, and which headaches should not wait

Most headaches on tirzepatide do not require urgent attention. But some do, and it is important to be specific about which ones. Seek medical help promptly if you experience any of the following: a headache that is severe or comes on suddenly and feels unlike any you have had before; a headache accompanied by visual changes, confusion, weakness, or difficulty speaking; a headache that arrives alongside severe, persistent stomach pain that radiates toward the back (which could signal pancreatitis, a serious but infrequent side effect flagged in the MHRA's January 2026 Drug Safety Update for GLP-1 medicines); or any symptom combination that genuinely worries you.

Call 111 or your GP if you are unsure. Do not wait for your next scheduled review if something feels wrong. The Summary of Product Characteristics on the eMC contains the full list of symptoms that warrant immediate medical attention, it is worth reading, even briefly, when you start treatment.

If you experience a side effect you believe is linked to Mounjaro, you can report it directly via the MHRA's Yellow Card scheme. Patients can submit reports, you do not need to go through a doctor first. This reporting is genuinely useful; it is how the MHRA monitors medicines after they reach the real world.

You can read more about what to expect across different types of headache reported on Mounjaro, or check whether headaches are an official listed side effect of tirzepatide. Both pages draw on the same prescribing information and are written to the same clinical standards.

Discussing headaches as part of your consultation at nume

A side-effect question is a clinical question. Whether you are about to start Mounjaro and want to know what to expect, or you are already on treatment and finding headaches disruptive, a prescriber is the right person to talk through it with, not a forum, and not a label read in isolation.

At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber. A real clinician reads your answers, considers your full health picture, and decides whether treatment is suitable for you, side-effect history included. If you are already a patient and something changes, our aftercare team is available seven days a week. You do not need to wait for your next pen to arrive. When your treatment does arrive (tracked by DPD, in a plain unbranded box) the patient information leaflet inside is worth keeping; it is the clearest single-document reference for managing anything that comes up between reviews.

To learn more about Mounjaro as a treatment, the Mounjaro overview page covers the evidence, the licence and the process. Or if you are ready to talk through your options, speak to our prescribers via a free consultation.